SCHEMBL13403281

SCHEMBL13403281

CC(=O)c1c(C)c(C)c(C)oc1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 1/20 0.39
CYP3A4 P08684 1/20 0.39
CA9 Q16790 6/20 0.38
CA12 O43570 5/20 0.38
BRD4 O60885 1/20 0.37
BRPF1 P55201 1/20 0.37
CREBBP Q92793 1/20 0.37
MAPT P10636 3/20 0.36
HTT P42858 3/20 0.36
MITF O75030 1/20 0.36
LMNA P02545 1/20 0.36
POLB P06746 2/20 0.34
ALDH1A1 P00352 4/20 0.33
GAA P10253 3/20 0.32
KDM4E B2RXH2 3/20 0.32
HSD17B10 Q99714 1/20 0.31
ALDH1A2 O94788 1/20 0.31
ALDH2 P05091 1/20 0.31
ALDH1B1 P30837 1/20 0.31
ALDH1A3 P47895 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15233112 0.83 CA9 (0.47) CYP1A2CYP3A4CA9CA12BRD4
SCHEMBL13403284 0.78 CYP1A2 (0.36) CYP1A2CYP3A4CA9CA12BRD4
SCHEMBL7965644 0.76 CA9 (0.49) CYP1A2CYP3A4CA9CA12MAPT
SCHEMBL5633583 0.71 CA9 (0.47) CYP1A2CYP3A4CA9CA12MAPT
SCHEMBL19149846 0.71 CYP3A4 (0.48) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL11843818 0.69 POLB (0.57) CYP1A2CYP3A4CA9MAPTHTT
SCHEMBL7965502 0.69 CA12 (0.42) CA9CA12BRD4BRPF1CREBBP
SCHEMBL25177428 0.69 POLB (0.33) POLB
SCHEMBL30932977 0.68 CYP3A4 (0.46) CYP1A2CYP3A4BRD4BRPF1CREBBP
SCHEMBL11893177 0.68 CYP3A4 (0.46) CYP1A2CYP3A4BRD4BRPF1CREBBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7691883-B2 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2010-04-06 US disclosed
US-20070265228-A1 Cinnamoyl compound and use of the same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-11-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070265228-A1 Cinnamoyl compound and use of the same NPC1, CES2, CYP51A1 CYP1A2 367/4885CYP3A4 561/4885CA9 133/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.